Medical Communications

UK ministers are close to deciding that double vaccinated people from the US and many EU countries will not have …

Alnylam Pharmaceuticals has announced that its investigational RNAi therapeutic, lumasiran, has performed well in a Phase III study for the …

The FDA has granted VICO’s investigational therapy for Huntingdon disease, VO659, orphan-drug designation. This news comes just one month after …

On Tuesday Tokyo reported 2,848 daily coronavirus infections, the city’s highest rate since the pandemic began. The new infection record …

A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …

NICE has published a new guideline covering C. difficile infection, the latest in the series of antimicrobial prescribing guidelines which …

UK researchers have found an eight-week gap between first and second doses of the Pfizer-BioNTech appears to be the “sweet …

Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …

In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …

Parents are being warned to be on the lookout for signs of a common childhood respiratory illness, RSV, as cases …

A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …

Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …

NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …

A new study posted online on Tuesday, has found that Johnson & Johnson’s COVID-19 vaccine is much less effective against …

Pfizer has reached a $345 million settlement over consumer claims they overpaid for EpiPens as a result of unfair, anticompetitive …